Question 1

What is LOPJLB’s current signal on CARM?

Accepted Answer

LOPJLB’s latest quantitative signal on Carisma Therapeutics, Inc. (CARM) is SELL in a CRISIS regime. Signals are updated daily.

Question 2

What market regime is CARM in?

Accepted Answer

Carisma Therapeutics, Inc. (CARM) is currently classified in the CRISIS HMM market regime on LOPJLB.

Question 3

What does Carisma Therapeutics, Inc. (CARM) do?

Accepted Answer

Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidates include CT-2401, which is in preclinical trial for the treatment of liver fibrosis. The company also develops CT-1119, a mesothelin-targeted CAR-Monocyte that is in phase I clinical trial to treat patients with advanc…

Question 4

Where is Carisma Therapeutics, Inc. based / listed?

Accepted Answer

Carisma Therapeutics, Inc. is based in US, listed on OTC.

Carisma Therapeutics, Inc. (CARM)

Key stats

Industry peers

Prediction markets

Company news